Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluvastatin Added to Standard Medical Treatment for Chronic Hepatitis C
NCT00487318Phase 2Completed
- Start
- Jun 2007
- Primary completion
- Oct 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of fluvastatin in hepatitis C (HCV) (2 arms). Primary endpoint: Sustained Viral Response at 72 weeks. Started Jun 2007; status: completed.
02
Drugs
fluvastatin
03
Conditions
hepatitis C (HCV)
Beyond the preview
Go deeper on NCT00487318.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00487318.